UROVYSION BLADDER CANCER RECURRENCE KIT

Bladder tumor-associated antigen · class III · Until 25/04/2033

Registration no.
10055311129
Process no.
25351001676200312
Status
Until 25/04/2033
Device type
Bladder tumor-associated antigen (ANTÍGENO ASSOCIADO AO TUMOR DE BEXIGA)
Risk class
III
Registration holder
ABBOTT LABORATORIOS DO BRASIL LTDA CNPJ 56.998.701/0001-16 · 2,467 registrations
Manufacturer
ABBOTT MOLECULAR INC · United States
Published
25/04/2003
Valid until
25/04/2033
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗